A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects

Conditions

• Chronic Obstructive Pulmonary Disease

Interventions

• DRUG: TQC3302 inhalation spray
• DRUG: TQC3302 inhalation spray+Tiotropium bromide and olodaterol hydrochloride inhalation spray +Budesonide Powder for Inhalation
• DRUG: Tiotropium bromide and olodaterol hydrochloride inhalation spray +Budesonide Powder for Inhalation+ TQC3302 inhalation spray
• DRUG: Budesonide Powder for Inhalation+ TQC3302 inhalation spray+ Tiotropium bromide and olodaterol hydrochloride inhalation spray
• DRUG: TQC3302 inhalation spray

Sponsor

Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.